Dyne Therapeutics, Inc. (DYN) Ownership

$24.57

south_east
-$0.19 (-0.77%)
Day's range
$24.02
Day's range
$24.84

Dyne Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 02/06/2025 8.02 M $188.94 M   -0.01% 7.95%
FMR LLC 02/13/2025 8.00 M $188.41 M   -11.41% 7.93%
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.95 M $187.29 M   1.99% 7.88%
JANUS HENDERSON GROUP PLC 02/14/2025 7.38 M $173.81 M   8.31% 7.31%
VANGUARD GROUP INC 02/11/2025 6.70 M $157.94 M   -2.33% 6.65%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 6.38 M $150.34 M   0.00% 6.33%
FCPM III SERVICES B.V. 02/14/2025 5.46 M $128.70 M   -8.25% 5.42%
RTW INVESTMENTS, LP 02/14/2025 5.22 M $122.95 M   -23.47% 5.17%
STATE STREET CORP 02/14/2025 3.72 M $87.58 M   2.07% 3.68%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 2.65 M $62.44 M   0.00% 2.63%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 2.40 M $56.60 M   -8.87% 2.38%
HOLOCENE ADVISORS, LP 02/14/2025 2.35 M $55.32 M   18.44% 2.33%
VR ADVISER, LLC 02/14/2025 2.17 M $51.22 M   0.00% 2.15%
DEEP TRACK CAPITAL, LP 02/14/2025 2.00 M $47.12 M   -39.06% 1.98%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 1.95 M $45.94 M   -18.85% 1.93%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.89 M $44.48 M   1.50% 1.87%
JEFFERIES FINANCIAL GROUP INC. 02/27/2025 1.80 M $42.41 M   100.00% 1.78%
SIREN, L.L.C. 02/14/2025 1.35 M $31.75 M   18.75% 1.34%
FRANKLIN RESOURCES INC 02/12/2025 1.32 M $31.19 M   -1.39% 1.31%
ORBIMED ADVISORS LLC 02/14/2025 1.23 M $28.91 M   73.22% 1.22%
JENNISON ASSOCIATES LLC 01/24/2025 1.21 M $28.55 M   -10.03% 1.20%
VIVO CAPITAL, LLC 02/13/2025 1.11 M $26.27 M   0.00% 1.11%
SOFINNOVA INVESTMENTS, INC. 02/14/2025 1.07 M $25.24 M   38.78% 1.06%
FEDERATED HERMES, INC. 02/13/2025 1.06 M $24.89 M   -13.22% 1.05%
ARMISTICE CAPITAL, LLC 02/14/2025 964,518 $22.72 M   -16.51% 0.96%
NORGES BANK 02/12/2025 950,104 $22.38 M   100.00% 0.94%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 932,231 $21.96 M   3.56% 0.92%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 924,681 $21.79 M   802.30% 0.92%
MAN GROUP PLC 02/14/2025 746,463 $17.59 M   3.87% 0.74%
MPM ASSET MANAGEMENT LLC 02/14/2025 682,376 $16.08 M   0.00% 0.68%
BRAIDWELL LP 02/14/2025 681,182 $16.05 M   100.00% 0.68%
BAKER BROS. ADVISORS LP 02/14/2025 672,096 $15.83 M   0.00% 0.67%
OCTAGON CAPITAL ADVISORS LP 02/14/2025 668,000 $15.74 M   154.26% 0.66%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 667,452 $15.73 M   2.90% 0.66%
GOLDMAN SACHS GROUP INC 02/11/2025 628,703 $14.81 M   -6.23% 0.62%
WOODLINE PARTNERS LP 02/14/2025 573,957 $13.52 M   -41.28% 0.57%
ECOR1 CAPITAL, LLC 02/14/2025 555,644 $13.09 M   0.00% 0.55%
PERCEPTIVE ADVISORS LLC 02/14/2025 543,277 $12.80 M   -24.35% 0.54%
UBS GROUP AG 02/14/2025 540,112 $12.73 M   -13.68% 0.54%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 474,528 $11.18 M   2.93% 0.47%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 450,000 $10.60 M   181.25% 0.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 435,653 $10.26 M   0.00% 0.43%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/14/2025 420,431 $9.91 M   -66.56% 0.42%
VIDA VENTURES ADVISORS, LLC 01/21/2025 407,499 $9.60 M   0.00% 0.40%
CANDRIAM S.C.A. 02/07/2025 401,395 $9.46 M   2.67% 0.40%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 332,277 $7.83 M   0.00% 0.33%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 323,552 $7.62 M   6.19% 0.32%
WASATCH ADVISORS LP 02/13/2025 320,626 $7.55 M   -1.07% 0.32%
ENSIGN PEAK ADVISORS, INC 02/14/2025 315,602 $7.44 M   0.91% 0.31%
FRONTIER CAPITAL MANAGEMENT CO LLC 02/14/2025 298,052 $7.02 M   100.00% 0.30%

Dyne Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 239 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:

Atlas Venture Life Science Advisors, LLC: 8.02 M

FMR LLC: 8 M

BlackRock Funding, Inc. /DE: 7.95 M

JANUS HENDERSON GROUP PLC: 7.38 M

VANGUARD GROUP INC: 6.7 M

RA CAPITAL MANAGEMENT, L.P.: 6.38 M

110.62% of Dyne Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 120.13 M shares in the last 24 months. This purchase volume represents approximately $2.95 B in transactions.